Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Samsung Bioepis-NIPRO alliance boosts biosimilar pipeline in Japan’s $1.4B market Samsung Bioepis (KRX: 207940) and NIPRO’s biosimilar partnership expands Japan market access amid rising healthcare costs and global biologics competition. bySoujanya RaviJune 9, 2025